What your lipid panel actually reports

A standard lipid panel measures four things: total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. From these, additional ratios can be calculated that are often more predictive of cardiovascular risk than any single value alone[1].

MarkerOptimalBorderlineHigh risk
Total cholesterol< 200 mg/dL200-239≥ 240
LDL cholesterol< 100 mg/dL100-159≥ 160
HDL cholesterol> 60 mg/dL40-59< 40
Triglycerides< 100 mg/dL100-149≥ 150
TG/HDL ratio< 2.02.0-3.5> 3.5

Total cholesterol: less useful than you think

Total cholesterol is the sum of HDL, LDL, and VLDL cholesterol. While it was the original screening metric, it is now recognized as a relatively poor predictor of cardiovascular events in isolation. A person with total cholesterol of 240 mg/dL might have an HDL of 80 and an LDL of 130 — a favorable profile. Another person at 240 might have an HDL of 35 and an LDL of 180 — a dangerous one[2].

The Framingham Heart Study established that total cholesterol above 240 mg/dL doubles cardiovascular risk compared to below 200 mg/dL. But the same study found that HDL was an independent and stronger predictor — each 1 mg/dL increase in HDL was associated with a 2-3% decrease in cardiovascular risk[3].

LDL: the primary driver of atherosclerosis

LDL (low-density lipoprotein) particles carry cholesterol from the liver to peripheral tissues. When present in excess, they penetrate the arterial wall, become oxidized, trigger an inflammatory response, and initiate the formation of atherosclerotic plaque. This is not a hypothesis — it is one of the most robustly supported causal relationships in all of medicine[4].

Mendelian randomization studies — which use genetic variants as natural experiments — have confirmed that lifelong exposure to lower LDL is associated with proportionally lower cardiovascular risk, independent of how the LDL was lowered (diet, statins, PCSK9 inhibitors, or genetic variation)[5].

Key distinction
Standard lipid panels report LDL cholesterol — the mass of cholesterol carried by LDL particles. But cardiovascular risk is more closely related to LDL particle number (LDL-P) and apolipoprotein B (ApoB), which count the actual particles. Two people with the same LDL-C can have very different particle counts. Advanced testing for ApoB is increasingly recommended by preventive cardiologists.

HDL: more complex than "good cholesterol"

HDL (high-density lipoprotein) performs reverse cholesterol transport — collecting excess cholesterol from peripheral tissues and artery walls and returning it to the liver for disposal. Epidemiologically, higher HDL is consistently associated with lower cardiovascular risk[3].

However, the relationship is more nuanced than "higher is always better." Pharmacological trials that raised HDL (with CETP inhibitors or niacin) did not reduce cardiovascular events, suggesting that the function of HDL particles matters more than their quantity[6]. Very high HDL (above 90-100 mg/dL) has even been associated with increased mortality in some studies, though this remains debated.

Triglycerides: the metabolic health signal

Triglycerides are the form in which dietary fat and excess carbohydrates are transported in the blood. They are the lipid component most responsive to lifestyle factors — particularly sugar intake, refined carbohydrates, alcohol, and physical activity[7].

While standard guidelines classify triglycerides below 150 mg/dL as "normal," accumulating evidence suggests that optimal levels are below 100 mg/dL. The Copenhagen General Population Study followed over 100,000 individuals and found that non-fasting triglycerides above 89 mg/dL were associated with progressively increasing cardiovascular risk[8].

The ratios that matter most

Triglyceride-to-HDL ratio

The TG/HDL ratio has emerged as one of the most powerful and practical lipid predictors. A ratio below 2.0 is associated with predominantly large, buoyant (less atherogenic) LDL particles. A ratio above 3.5 correlates with small, dense LDL — the particle pattern most strongly associated with coronary heart disease[9].

This ratio also serves as a surrogate marker for insulin resistance. Studies have shown that TG/HDL ratio correlates well with HOMA-IR (a standard measure of insulin resistance) and predicts incident diabetes[10].

Total cholesterol-to-HDL ratio

The TC/HDL ratio accounts for both the harmful and protective components. A ratio below 3.5 is considered optimal. Above 5.0 indicates elevated risk. This ratio has been shown in the Framingham data to be a better predictor of cardiovascular events than LDL alone[3].

A lipid panel is not five independent numbers — it is a system. The ratios between values tell you more about cardiovascular risk than any single number in isolation.

Beyond the standard panel: ApoB and Lp(a)

Apolipoprotein B (ApoB) is a single protein present on every atherogenic lipoprotein particle (LDL, VLDL, IDL, Lp(a)). Because each particle carries exactly one ApoB molecule, measuring ApoB directly counts the total number of atherogenic particles. The European Atherosclerosis Society consensus statement recommends ApoB as the preferred measurement over LDL-C for risk estimation[11].

Lipoprotein(a) — Lp(a) — is a genetically determined, highly atherogenic lipoprotein that is not captured by standard LDL measurement. Approximately 20% of the population has elevated Lp(a). Because it is genetically fixed and not responsive to lifestyle changes or statins, it should be measured at least once in a lifetime[12].

Lipa analyzes this panel
See your lipid panel in full context — ratios, trends, and what it means
Lipa reads your cholesterol, HDL, LDL, and triglycerides, calculates the ratios that actually predict risk, and explains what your results mean in plain language. Upload your blood test to see your cardiovascular picture.
Get started free

Lifestyle interventions for lipid improvement

Bottom line
Your lipid panel is more informative than most people realize. Look beyond total cholesterol to the components and ratios: triglyceride-to-HDL ratio for metabolic health and insulin resistance, LDL (and ideally ApoB) for atherogenic risk, and Lp(a) at least once to rule out genetic risk. The standard "good cholesterol / bad cholesterol" framing misses most of the actionable information these numbers contain.